AI Accelerator Grant Program Service

The agency is seeking a vendor to provide an artificial intelligence accelerator grant program service. This program supports international, AI-driven ovarian cancer research collaborations focused on improving prevention, early detection, treatment response, and patient outcomes. The initiative enables large-scale, data-intensive biomedical research using artificial intelligence, computational science, and clinical collaboration. The scope of work covers applying artificial intelligence to ovarian cancer biology, diagnosis, and treatment. Specific research areas include cancer prevention and initiation mechanisms, early detection and screening technologies, and tumor microenvironment and cancer ecosystem modeling. The program also targets treatment resistance and recurrence prediction, patient stratification and risk prediction models, medical imaging analysis, biomarker discovery, and AI-driven literature synthesis. Eligible bidders must be onshore organizations based in the United States. The agency requires the performance of all work to be conducted offsite. The agency is currently looking for proposals to determine the budget, and no specific key dates or evaluation criteria are provided in the source.